Zobrazeno 1 - 10
of 76
pro vyhledávání: '"R. Schilder"'
Autor:
J. Gillen, A. Miller, K.N. Moore, K.M. Bell-McGuinn, R. Schilder, J.L. Walker, W.E. Brady, R.E. O'Cearbhaill, S.R. Guntupalli, D.K. Armstrong, A.R. Hagemann, H.J. Gray, L.R. Duska, C.A. Mathews, A. Chen, D.M. O'Malley, S.W. Gordon, P.M. Fracasso, C. Aghajanian
Publikováno v:
Gynecologic Oncology. 159:15-16
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Lawrence M. Lichtenstein, ED King, David M. Essayan, Anne Kagey-Sobotka, R Schilder, MK Jenkens, O Korzeniowski
Publikováno v:
Bone Marrow Transplantation. 19:749-752
Anaphylaxis has been reported in subjects receiving peripheral blood precursor cell (PBPC) infusions; however the etiologic agent is unclear. Basophils from a PBPC-allergic subject were challenged with each individual component of the stem cell infus
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
E, Berman, R A, Clift, E A, Copelan, P D, Emanuel, H P, Erba, M J, Glenn, P L, Greenberg, R J, Jones, S, O'Brien, H I, Saba, R, Schilder, D S, Snyder, R J, Soiffer, M S, Tallman, M, Wetzler, F, Ravandi-Kashani, H, Kantarjian, M, Talpaz
Publikováno v:
Oncology (Williston Park, N.Y.). 14(11A)
Publikováno v:
Cancer chemotherapy and biological response modifiers. 18
Publikováno v:
Cancer chemotherapy and biological response modifiers. 17
In conclusion, significant advances have been made in ovarian cancer. Specifically, these relate to the success of paclitaxel and platinum-based regimens. The appropriate scheduling, dosing, and the selection of carboplatin vs cisplatin remains contr
Publikováno v:
Bone marrow transplantation. 15(2)
Autor:
P J, O'Dwyer, G R, Hudes, J, Walczak, R, Schilder, F, LaCreta, B, Rogers, I, Cohen, C, Kowal, L, Whitfield, R A, Boyd
Publikováno v:
Cancer research. 52(24)
CI-973, a platinum(II) derivative with a 2-methyl-1,4-butanediamine carrier ligand, has activity in cisplatin-resistant tumor models in vitro and in vivo. In a Phase I pharmacokinetic study, 31 patients were treated with CI-973 (24 to 50 mg/m2/day fo
Autor:
P J, O'Dwyer, F, LaCreta, S, Nash, P W, Tinsley, R, Schilder, M L, Clapper, K D, Tew, L, Panting, S, Litwin, R L, Comis
Publikováno v:
Cancer research. 51(22)
The glutathione transferases comprise a family of isoenzymes, one or more of which are involved in the conjugation of alkylating agents to glutathione (GSH). Increased GSH transferase activity has been shown to underlie acquired resistance to several